Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
drug approvals
Pharma
Day One pressures Novartis with FDA nod for novel RAF inhibitor
Compared with Novartis' BRAF offering, Day One's Ojemda covers a broader patient population in pediatric low-grade glioma.
Angus Liu
Apr 23, 2024 10:13pm
Soon-Shiong's ImmunityBio bags FDA nod for bladder cancer drug
Apr 22, 2024 10:40pm
BeiGene finally snags FDA approval for PD-1 drug Tevimbra
Mar 15, 2024 8:39am
FDA approves first T-cell therapy for a solid tumor
Feb 17, 2024 12:15pm
Takeda snags FDA nod for once-snubbed Eohilia to go after Sanofi
Feb 12, 2024 11:18am
Leqembi, Takeda, Roche—Fierce Pharma Asia
Feb 9, 2024 9:02am